#9,183 by institutional money · Stock
Intensity Therapeutics, Inc. (INTS)
Institutional ownership from Q3 2026 Form 13F filings
$2.50
−5.30% today
Market closed. Prices as of Nov 20, 8:11 AM ET
- 13F holders
- 15 (−1)
- Held by 13F filers, live
- $2.2M
- Shares held
- 873,520
- Share of stock outstanding
- 26.5%
- Net buying in Q3 2026
- +$503K
- New positions / sold out
- 2 / 3
Largest holders
15 investors| Investor | Shares | Value, live | % of their portfolio | vs Q2 2026 |
|---|---|---|---|---|
| Kingsbury Capital Investment Advisors LLC | 706,523 | $1.8M | 1.88% | Added +42% |
| Rothschild Wealth LLC | 29,219 | $73K | <0.1% | Added +9% |
| Vanguard Capital Management LLC | 26,569 | $66K | <0.1% | Unchanged |
| Nano Cap New Millennium Growth Fund L P | 25,000 | $63K | <0.1% | Unchanged |
| Geode Capital Management, LLC | 22,238 | $56K | <0.1% | Reduced −2% |
| Vanguard Fiduciary Trust Co | 21,066 | $53K | <0.1% | Added +131% |
| FNY Investment Advisers, LLC | 15,798 | $39K | <0.1% | Reduced −28% |
| Mesirow Financial Investment Management, Inc. | 14,040 | $35K | <0.1% | Reduced −1% |
| State Street Corp | 10,648 | $27K | <0.1% | New |
| NewEdge Advisors, LLC | 1,148 | $3K | <0.1% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,004 | $3K | <0.1% | Reduced −49% |
| Citigroup Inc | 234 | $585 | <0.1% | New |
| Barclays Plc | 26 | $65 | <0.1% | Reduced −38% |
| Caitong International Asset Management Co., Ltd | 6 | $15 | <0.1% | Unchanged |
| UBS Group AG | 1 | $3 | <0.1% | Unchanged |